Structural basis for high-affinity peptide inhibition of p53 interactions with MDM2 and MDMX

Coot : model-building tools for molecular graphics

Emsley, P., & Cowtan, K. (2004) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444904019158 · Cited by 30,571

Dictionary of protein secondary structure: Pattern recognition of hydrogen‐bonded and geometrical features

Kabsch, W., & Sander, C. (1983) · Biopolymers · doi:10.1002/bip.360221211 · Cited by 15,320

Refinement of Macromolecular Structures by the Maximum-Likelihood Method

Murshudov, G. N., Vagin, A. A., & Dodson, E. J. (1997) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444996012255 · Cited by 14,796

Surfing the p53 network

Vogelstein, B., Lane, D., & Levine, A. J. (2000) · Nature · doi:10.1038/35042675 · Cited by 6,607

In Vivo Activation of the p53 Pathway by Small-Molecule Antagonists of MDM2

Vassilev, L. T., Vu, B. T., Graves, B., Carvajal, D., Podlaski, F., Filipovic, Z., Kong, N., Kammlott, U., Lukacs, C., Klein, C., et al. (2004) · Science · doi:10.1126/science.1092472 · Cited by 4,661

Mdm2 promotes the rapid degradation of p53

Haupt, Y., Maya, R., Kazaz, A., & Oren, M. (1997) · Nature · doi:10.1038/387296a0 · Cited by 4,506

Synthesis of Proteins by Native Chemical Ligation

Dawson, P. E., Muir, T. W., Clark‐Lewis, I., & Kent, S. B. H. (1994) · Science · doi:10.1126/science.7973629 · Cited by 4,190

How to measure and predict the molar absorption coefficient of a protein

Pace, C., Vajdos, F., Fee, L. R., Grimsley, G., & Gray, T. (1995) · Protein Science · doi:10.1002/pro.5560041120 · Cited by 3,924

Regulation of p53 stability by Mdm2

Kubbutat, M. H. G., Jones, S. N., & Vousden, K. H. (1997) · Nature · doi:10.1038/387299a0 · Cited by 3,312 · cited 1×

Live or let die: the cell's response to p53

Vousden, K. H., & Lü, X. (2002) · Nature reviews. Cancer · doi:10.1038/nrc864 · Cited by 3,231

Avoiding drug resistance through extended drug target interfaces: a case for stapled peptides

Wei, S. J., Chee, S. M. Q., Yurlova, L., Lane, D. P., Verma, C. S., Brown, C. J., & Ghadessy, F. J. (2016) · Oncotarget · doi:10.18632/oncotarget.8572 · Cited by 16

A Computational Investigation of Small-Molecule Engagement of Hot Spots at Protein–Protein Interaction Interfaces

Xu, D. D., Si, Y., & Meroueh, S. O. (2017) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.7b00181 · Cited by 16

Systematic ‘foldamerization’ of peptide inhibiting p53-MDM2/X interactions by the incorporation of trans- or cis-2-aminocyclopentanecarboxylic acid residues

Fortuna, P., Twarda‐Clapa, A., Skalniak, Ł., Ożga, K., Holak, T. A., & Berlicki, Ł. (2020) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2020.112814 · Cited by 16

Apamin as a Template for Structure‐Based Rational Design of Potent Peptide Activators of p53

Li, C., Pazgier, M., Liu, M., Lu, W., & Lu, W. (2009) · Angewandte Chemie · doi:10.1002/ange.200904550 · Cited by 16

Highly sensitive protein detection based on a novel probe with catalytic activity combined with a signal amplification strategy: assay of MDM2 for cancer staging

Li, H., Xie, H., Huang, Y., Bo, B., Zhu, X., Shu, Y., & Li, G. (2013) · Chemical Communications · doi:10.1039/c3cc45529g · Cited by 15

Markov State Models to Elucidate Ligand Binding Mechanism

Ge, Y., & Voelz, V. A. (2021) · Methods in molecular biology · doi:10.1007/978-1-0716-1209-5_14 · Cited by 14

Red-light modulated ortho -chloro azobenzene photoswitch for peptide stapling via aromatic substitution

Kapun, M., Pérez-Areales, F. J., Ashman, N., Rowling, P. J. E., Schober, T., Fowler, E., Itzhaki, L. S., & Spring, D. R. (2023) · RSC Chemical Biology · doi:10.1039/d3cb00176h · Cited by 15

MDMX in Cancer: A Partner of p53 and a p53-Independent Effector

Wu, L., Yan, Y., Huang, Q., & Zheng, D. (2024) · Biologics · doi:10.2147/btt.s436629 · Cited by 17

Guanidinium‐Stapled Helical Peptides for Targeting Protein‐Protein Interactions

Perdriau, C., Luton, A., Zimmeter, K., Neuville, M., Saragaglia, C., Peluso‐Iltis, C., Ősz, J., Kauffmann, B., Collie, G. W., Rochel, N., et al. (2024) · Angewandte Chemie International Edition · doi:10.1002/anie.202416348 · Cited by 15

Human Serum Albumin and p53-Activating Peptide Fusion Protein Is Able to Promote Apoptosis and Deliver Fatty Acid-Modified Molecules

Joshi, M. R., Yao, N., Myers, K. A., & Li, Z. (2013) · PLoS ONE · doi:10.1371/journal.pone.0080926 · Cited by 15

Pattern enrichment analysis for phage selection of stapled peptide ligands

Miki, T., Namii, K., Seko, K., Kakehi, S., Moro, G., & Mihara, H. (2022) · Chemical Science · doi:10.1039/d2sc04058a · Cited by 15

A mix-and-read drop-based in vitro two-hybrid method for screening high-affinity peptide binders

Cui, N., Zhang, H., Schneider, N., Tao, Y., Asahara, H., Sun, Z., Cai, Y., Koehler, S. A., de Greef, T. F. A., Abbaspourrad, A., et al. (2016) · Scientific Reports · doi:10.1038/srep22575 · Cited by 15

A quantitative intracellular peptide-binding assay reveals recognition determinants and context dependence of short linear motifs

Subbanna, M. S., Winters, M. J., Örd, M., Davey, N. E., & Pryciak, P. M. (2025) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2025.108225 · Cited by 16

Bacterial Systems as a Precision Delivery Platform of Therapeutic Peptides for Cancer Therapy

Liu, J., Shen, G., & Yan, X. (2025) · Polymer science & technology. · doi:10.1021/polymscitech.4c00026 · Cited by 14

Disulfide trapping of protein complexes on the yeast surface

Lim, K. H., Madabhushi, S. R., Mann, J. K., Neelamegham, S., & Park, S. (2009) · Biotechnology and Bioengineering · doi:10.1002/bit.22651 · Cited by 14

Solution-State Preorganization of Cyclic β-Hairpin Ligands Determines Binding Mechanism and Affinities for MDM2

Ge, Y., Zhang, S., Erdélyi, M., & Voelz, V. A. (2021) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.1c00029 · Cited by 13

MDM4 binds ligands via a mechanism in which disordered regions become structured

Sanchez, M. C., Renshaw, J., Davies, G. M., Barlow, P. N., & Vogtherr, M. (2010) · FEBS Letters · doi:10.1016/j.febslet.2010.05.058 · Cited by 14

FRETting about the affinity of bimolecular protein–protein interactions

Lin, T., Scott, B. L., Hoppe, A. D., & Chakravarty, S. (2018) · Protein Science · doi:10.1002/pro.3482 · Cited by 16

Synthesis by native chemical ligation and crystal structure of human CCL2

Grygiel, T. L. R., Teplyakov, A., Obmolova, G., Stowell, N. C., Holland, R., Nemeth, J. F., Pomerantz, S. C., Kruszynski, M., & Gilliland, G. L. (2010) · Biopolymers · doi:10.1002/bip.21390 · Cited by 15

How to choose templates for modeling of protein complexes: Insights from benchmarking template-based docking

Chakravarty, D., McElfresh, G., Kundrotas, P. J., & Vakser, I. A. (2020) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.25875 · Cited by 13

A Covalent Self-Reporting Peptide Degrader Enables Real-Time Monitoring of Targeted Protein Degradation In Vivo

Zhang, W., Yuan, L., Liu, R., Jing, Y., Lin, S., Fang, H., Li, Y., Zhang, X., Dai, J. Y., Liu, T., et al. (2025) · Journal of the American Chemical Society · doi:10.1021/jacs.5c07041 · Cited by 13

Amino acid-based biomaterials for modulation of cell behaviors: from mechanisms to biomedical applications

Liu, M., Chen, J., Li, H., Ma, Y., Xiao, Q., Ding, J., Li, J., & Chen, X. (2026) · Chemical Society Reviews · doi:10.1039/d5cs01504a · Cited by 15

Investigation of the MDM2-binding potential of de novo designed peptides using enhanced sampling simulations

Durojaye, O. A., Yekeen, A. A., Idris, M. O., Okoro, N. O., Odiba, A. S., & Nwanguma, B. C. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.131840 · Cited by 15

Exploring the Potential of Cyclic Peptidyl Antitumor Agents Derived from Natural Macrocyclic Peptide Phakellistatin 13

Li, T., Jiang, S., Li, T., Xu, H., Zhang, X., Yan, R., Wu, X., Jin, Y., & Wang, Z. (2024) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.4c00393 · Cited by 13

Therapeutic peptides and their delivery using lipid-based nanoparticles

Yen, J.-H., Chang, C., Wu, T., Yang, C.-H., Hsu, H., & Liou, J.-W. (2025) · Tzu Chi Medical Journal · doi:10.4103/tcmj.tcmj_321_24 · Cited by 13

Targeting the conformational transitions of MDM2 and MDMX: Insights into key residues affecting p53 recognition

Carotti, A., Macchiarulo, A., Giacchè, N., & Pellicciari, R. (2009) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.22464 · Cited by 13

Exploiting Protein Corona around Gold Nanoparticles Conjugated to p53 Activating Peptides To Increase the Level of Stable p53 Proteins in Cells

Chan, K. P., Chao, S., & Kah, J. C. Y. (2019) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.9b00032 · Cited by 11

Real-time surface plasmon resonance monitoring of site-specific phosphorylation of p53 protein and its interaction with MDM2 protein

Wu, L., He, Y., Hu, Y., Lu, H., Cao, Z. Y., Yi, X., & Wang, J. (2019) · The Analyst · doi:10.1039/c9an01121h · Cited by 13

A computational analysis of interaction mechanisms of peptide and non-peptide inhibitors with MDMX based on molecular dynamics simulation

Cheng, W.-Y., Chen, J., Liang, Z.-Q., Li, G., Yi, C., Wang, W., & Wang, K.-Y. (2012) · Computational and Theoretical Chemistry · doi:10.1016/j.comptc.2012.01.010 · Cited by 13

A Novel Cell-Based Intracellular Protein–Protein Interaction Detection Platform (SOLIS) for Multimodality Screening

Kashima, D., Kageoka, M., Kimura, Y., Horikawa, M., Miura, M., Nakakido, M., Tsumoto, K., Nagamune, T., & Kawahara, M. (2021) · ACS Synthetic Biology · doi:10.1021/acssynbio.0c00483 · Cited by 12

DFT-aided infrared and electronic circular dichroism spectroscopic study of cyclopeptide S-PK6 and the exploration of its antitumor potential by molecular docking

Zhang, X., Li, T., Zhao, L., Xu, H., Chang, Y., Jin, Y., & Wang, Z. (2023) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2023.134903 · Cited by 12

Molecular Interaction Fields and 3D-QSAR Studies of p53−MDM2 Inhibitors Suggest Additional Features of Ligand−Target Interaction

Dezi, C., Carotti, A., Magnani, M., Baroni, M., Padova, A., Cruciani, G., Macchiarulo, A., & Pellicciari, R. (2010) · Journal of Chemical Information and Modeling · doi:10.1021/ci100113p · Cited by 12

Analysis and Design of Piezoelectric Braille Display

Smithmaitrie, P. (2009) · InTech eBooks · doi:10.5772/7391 · Cited by 12

Solid-phase synthesis and screening of N-acylated polyamine (NAPA) combinatorial libraries for protein binding

Iera, J. A., Jenkins, L. M. M., Kajiyama, H., Kopp, J. B., & Appella, D. H. (2010) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2010.09.054 · Cited by 12

A novel protease activity assay method based on an engineered autoinhibited protein using an enzyme-linked immunoassay

Yoon, H. K., & Yoo, T. H. (2013) · The Analyst · doi:10.1039/c3an01336g · Cited by 12

Topoisomeric Membrane-Active Peptides: A Review of the Last Two Decades

Carrera-Aubesart, A., Gallo, M., Defaus, S., Todorovski, T., & Andreu, D. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15102451 · Cited by 11

Protein grafting of p53TAD onto a leucine zipper scaffold generates a potent HDM dual inhibitor

Lee, J., Kang, E., Lee, J., Kim, J., Lee, K. H., Han, J., Kang, H. Y., Ahn, S.-S., Oh, Y., Shin, D., et al. (2014) · Nature Communications · doi:10.1038/ncomms4814 · Cited by 13

Structure-activity studies of Mdm2/Mdm4-binding stapled peptides comprising non-natural amino acids

Chee, S. M. Q., Wongsantichon, J., Siau, J. W., Thean, D., Ferrer, F. J., Robinson, R. C., Lane, D. P., Brown, C. J., & Ghadessy, F. J. (2017) · PLoS ONE · doi:10.1371/journal.pone.0189379 · Cited by 11

Synthetic 10FN3-based mono- and bivalent inhibitors of MDM2/X function

Lau, S. Y., Siau, J. W., Sobota, R. M., Wang, C. I., Zhong, P., Lane, D. P., & Ghadessy, F. J. (2018) · Protein Engineering Design and Selection · doi:10.1093/protein/gzy018 · Cited by 11

Identification of Secondary Binding Sites on Protein Surfaces for Rational Elaboration of Synthetic Protein Mimics

Torner, J. M., Yang, Y., Rooklin, D. W., Zhang, Y., & Arora, P. S. (2021) · ACS Chemical Biology · doi:10.1021/acschembio.1c00418 · Cited by 11

Probing Difference in Binding Modes of Inhibitors to MDMX by Molecular Dynamics Simulations and Different Free Energy Methods

Shi, S., Zhang, S., & Zhang, Q. (2015) · PLoS ONE · doi:10.1371/journal.pone.0141409 · Cited by 10

Identification of a Structural Determinant for Selective Targeting of HDMX

Ben‐Nun, Y., Seo, H., Harvey, E. P., Hauseman, Z. J., Wales, T. E., Newman, C. E., Cathcart, A. M., Engen, J. R., Dhe‐Paganon, S., & Walensky, L. D. (2020) · Structure · doi:10.1016/j.str.2020.04.011 · Cited by 10

Nuclear delivery of dual anti-cancer drugs by molecular self-assembly

Wu, J., Ding, W., Han, G., You, W., Gao, W., Shen, H., Tang, J., Tang, Q., & Wang, X. (2020) · Biomaterials Science · doi:10.1039/d0bm00971g · Cited by 10

Bicyclic stapled peptides based on p53 as dual inhibitors for the interactions of p53 with MDM2 and MDMX

Li, H., Chen, X., Wu, M., Song, P., & Zhao, X. (2021) · Chinese Chemical Letters · doi:10.1016/j.cclet.2021.08.130 · Cited by 11

Affinity Selection from Synthetic Peptide Libraries Enabled by De Novo MS/MS Sequencing

Koh, L. Q., Lim, Y. W., & Gates, Z. P. (2022) · International Journal of Peptide Research and Therapeutics · doi:10.1007/s10989-022-10370-9 · Cited by 11

Rapid screening of protein–protein interaction inhibitors using the protease exclusion assay

Nirantar, S., Li, X. O., Siau, J. W., & Ghadessy, F. J. (2014) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2013.12.060 · Cited by 10

D ‐Peptide‐Based Drug Discovery Aided by Chemical Protein Synthesis

Zhao, L., & Lu, W. (2011) · Israel Journal of Chemistry · doi:10.1002/ijch.201100085 · Cited by 10

hDM2 protein-binding peptides screened from stapled α-helical peptide phage display libraries with different types of staple linkers

Anananuchatkul, T., Tsutsumi, H., Miki, T., & Mihara, H. (2020) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2020.127605 · Cited by 9

Bridged Analogues for p53-Dependent Cancer Therapy Obtained by S-Alkylation

Micewicz, E. D., Sharma, S. K., Waring, A. J., Luong, H. T., McBride, W. H., & Ruchala, P. P. (2015) · International Journal of Peptide Research and Therapeutics · doi:10.1007/s10989-015-9487-3 · Cited by 11

-Amino acid mutation of PMI as potent dual peptide inhibitors of p53-MDM2/MDMX interactions

Li, X., Liu, C., Chen, S., Hu, H., Su, J., & Zou, Y. (2017) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2017.09.014 · Cited by 10

Cell-Permeable Peptide Inhibitors of the p53-hDM2 Interaction via Foldamer Helix Mimicry and Bis-Thioether Stapling

Neuville, M., Bourgeais, M., Li, B., Varajao, L., Hallé, F., Goudreau, S. R., Thinon, E., Pasco, M., Khatib, A., & Guichard, G. (2024) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.4c01762 · Cited by 10

Gas‐phase conformations of intrinsically disordered proteins and their complexes with ligands: Kinetically trapped states during transfer from solution to the gas phase

Han, J. Y., Choi, T. S., Heo, C. E., Son, M. K., & Kim, H. I. (2019) · Mass Spectrometry Reviews · doi:10.1002/mas.21596 · Cited by 9

Targeting of p53 peptide analogues to anti-apoptotic Bcl-2 family proteins as revealed by NMR spectroscopy

Shin, J., Ha, J., & Chi, S. (2013) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2013.12.054 · Cited by 9

Designing dual inhibitors of Mdm2/MdmX: Unexpected coupling of water with gatekeeper Y100/99

Lee, X. A., Verma, C. S., & Sim, A. Y. L. (2017) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.25310 · Cited by 9

Functional profiling of p53-binding sites in Hdm2 and Hdmx using a genetic selection system

Datta, S., Bucks, M. E., Koley, D., Lim, P. X., & Savinov, S. N. (2010) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2010.06.053 · Cited by 9

Rapid alchemical free energy calculation employing a generalized born implicit solvent model.

Ostermeir, K., & Zacharias, M. (2015) · Journal of Physical Chemistry B · doi:10.1021/jp506367y · Cited by 8

Rapid identification of dual p53-MDM2/MDMX interaction inhibitors through virtual screening and hit-based substructure search

Chen, S., Li, X., Yuan, W., Zou, Y., Guo, Z., Chai, Y., & Lu, W. (2017) · RSC Advances · doi:10.1039/c7ra00473g · Cited by 9

Rapid and accurate structure‐based therapeutic peptide design using GPU accelerated thermodynamic integration

Garton, M., Corbi‐Verge, C., Hu, Y., Nim, S., Tarasova, N. I., Sherborne, B. S., & Kim, P. M. (2018) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.25644 · Cited by 9

Disulfide-Directed Multicyclic Peptides with N-Terminally Extendable α-Helices for Recognition and Activation of G Protein-Coupled Receptors

Fan, S., Li, J., Zhuang, J., Zhou, Q., Mai, Y., Lin, B., Wang, M., & Wu, C. (2024) · Journal of the American Chemical Society · doi:10.1021/jacs.4c12808 · Cited by 8

Exploring the Effect of Hydrocarbon Cross‐Linkers on the Structure and Binding of Stapled p53 Peptides

Choudhury, A. R., Gaikwad, V., Maity, A., & Chakrabarti, R. (2025) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.26793 · Cited by 9

Engineering Optogenetic Control of Endogenous p53 Protein Levels

Wehler, P., & Ventura, B. D. (2019) · Applied Sciences · doi:10.3390/app9102095 · Cited by 8

A Left‐Handed Solution to Peptide Inhibition of the p53–MDM2 Interaction

Liu, M., Pazgier, M., Li, C., Yuan, W., Li, C., & Lu, W. (2010) · Angewandte Chemie · doi:10.1002/ange.201000329 · Cited by 10

Molecular electrostatic potential and volume-aided drug design based on the isoindolinone-containing cyclopeptide S-PK6

Zhao, L., Li, T., Xu, H., Zhang, X., Lin, H., Liu, N., Jin, Y., & Wang, Z. (2023) · New Journal of Chemistry · doi:10.1039/d3nj01202f · Cited by 9

Benzyl stapled modification and anticancer activity of antimicrobial peptide A4K14-Citropin 1.1

Shen, H., Zhang, N., Kong, X., Wang, N., Hu, H., Cong, W., & Liu, C. (2023) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2023.129499 · Cited by 8

Insight into the interaction mechanism of inhibitors P4 and WK23 with MDM2 based on molecular dynamics simulation and different free energy methods

Shi, S., Zhang, S., & Zhang, Q. (2014) · Computational and Theoretical Chemistry · doi:10.1016/j.comptc.2014.07.002 · Cited by 8

Robust, Quantitative Analysis of Proteins using Peptide Immunoreagents, in Vitro Translation, and an Ultrasensitive Acoustic Resonant Sensor

Jalali‐Yazdi, F., Corbin, J. M., Takahashi, T. T., & Roberts, R. W. (2014) · Analytical Chemistry · doi:10.1021/ac500084d · Cited by 8

Molecular design and validation of halogen bonding orthogonal to hydrogen bonding in breast cancer MDM2–peptide complex

Huang, A., Zhou, L. Y., Zhang, D., Yao, J., & Zhang, Y. (2016) · Journal of Molecular Graphics and Modelling · doi:10.1016/j.jmgm.2016.09.007 · Cited by 8

A Fusion Protein of the p53 Transaction Domain and the p53-Binding Domain of the Oncoprotein MdmX as an Efficient System for High-Throughput Screening of MdmX Inhibitors

Chen, R., Zhou, J., Qin, L., Chen, Y., Huang, Y., Liu, H., & Su, Z. (2017) · Biochemistry · doi:10.1021/acs.biochem.7b00085 · Cited by 8

Computational modeling of cyclic peptide inhibitor–MDM2/MDMX binding through global docking and Gaussian accelerated molecular dynamics simulations

Wang, Y.-T., & Cheng, T. (2020) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2020.1773317 · Cited by 8

Facile synthesis, optical and conformational characteristics, and efficient intracellular delivery of a peptide–DNA conjugate

Lee, M.-K., & Lim, Y. (2014) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2014.05.041 · Cited by 7

Mechanistic insights into RNase L through use of an MDMX-derived multi-functional protein domain

Garvie, C. W., Vasanthavada, K., & Xiang, Q. (2013) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2013.04.010 · Cited by 7

Structure and dynamics of the retro-form of the bacteriophage T5 endolysin

Kutyshenko, V. P., Mikoulinskaia, G. V., Molochkov, N. V., Prokhorov, D. A., Таран, С. А., & Uversky, V. N. (2016) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2016.06.018 · Cited by 7

Rigorous Computational and Experimental Investigations on MDM2/MDMX-Targeted Linear and Macrocyclic Peptides

Diller, D., Swanson, J., Bayden, A. S., Brown, C. J., Thean, D., Lane, D. P., Partridge, A. W., Sawyer, T. K., & Audie, J. (2019) · Molecules · doi:10.3390/molecules24244586 · Cited by 7

Construction of Peptide Library in Mammalian Cells by dsDNA-Based Strategy

Su, W., Wang, Y., Zou, S., Zhao, Y., Li, Y., Zhang, C., Guo, X., & Li, S. (2022) · ACS Omega · doi:10.1021/acsomega.2c06402 · Cited by 7

Identification of Small Molecules Affecting p53-MDM2/MDMX Interaction by Fluorescence Polarization

Zhang, Q., & Lu, H. (2012) · Methods in molecular biology · doi:10.1007/978-1-62703-236-0_8 · Cited by 7

Jetzt wird es ernst: strukturbasiertes Design von Mdm2/Mdmx‐p53‐Inhibitoren

Popowicz, G. M., Dömling, A. S. S., & Holak, T. A. (2011) · Angewandte Chemie · doi:10.1002/ange.201003863 · Cited by 7

Natural Functions and Structure–Activity Relationships of Cyclotides

Oguis, G. K., Kan, M., & Craik, D. J. (2015) · Advances in botanical research · doi:10.1016/bs.abr.2015.10.001 · Cited by 7

Macrocyclization and labeling of helix–loop–helix peptide with intramolecular bis‐thioether linkage

Nishihara, T., Kitada, H., Fujiwara, D., & Fujii, I. (2016) · Biopolymers · doi:10.1002/bip.22826 · Cited by 8

Rational Design of an Orthogonal Molecular Interaction System at the Complex Interface of Lung Cancer-Related MDM2 Protein with p53 Peptide

Li, Y., Yu, X., Lou, Y., & Wang, T. (2016) · Australian Journal of Chemistry · doi:10.1071/ch16096 · Cited by 7

A Chemically Inducible Helper Module for Detecting Protein–Protein Interactions with Tunable Sensitivity Based on KIPPIS

Kashima, D., Kawade, R., Nagamune, T., & Kawahara, M. (2017) · Analytical Chemistry · doi:10.1021/acs.analchem.6b04063 · Cited by 7

Development and structural characterization of an engineered multi-copper oxidase reporter of protein–protein interactions

Sana, B., Chee, S. M. Q., Wongsantichon, J., Raghavan, S. S., Robinson, R. C., & Ghadessy, F. J. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.007141 · Cited by 7

A Cyclized Helix‐Loop‐Helix Peptide as a Molecular Scaffold for the Design of Inhibitors of Intracellular Protein–Protein Interactions by Epitope and Arginine Grafting

Fujiwara, D., Kitada, H., Oguri, M., Nishihara, T., Michigami, M., Shiraishi, K., Yuba, E., Nakase, I., Im, H., Cho, S., et al. (2016) · Angewandte Chemie · doi:10.1002/ange.201603230 · Cited by 7

Inhibition of protein-protein interactions using biodegradable depsipeptide nanoassemblies

Choi, S.-H., Hwang, H.-S., Han, S., Eom, H., Choi, J. S., Han, S., Lee, D., Lee, S. Y., Koo, H., Kwon, H. J., et al. (2023) · Journal of Controlled Release · doi:10.1016/j.jconrel.2023.12.028 · Cited by 6

Inhibiting mechanism of small molecule toward the p53‐ MDM 2 interaction: A molecular dynamic exploration

Chen, J., Wang, J., Pang, L., & Zhu, W. (2018) · Chemical Biology & Drug Design · doi:10.1111/cbdd.13345 · Cited by 7

Revealing binding selectivity of ligands toward murine double minute 2 and murine double minute X based on molecular dynamics simulations and binding free energy calculations

Shi, S., Sui, K., Liu, W., Lei, Y., Zhang, S., & Zhang, Q. (2019) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2019.1695671 · Cited by 6

Synthesis of Amino Acids Bearing Halodifluoromethyl Moieties and Their Application to p53-Derived Peptides Binding to Mdm2/Mdm4

Vaas, S., Zimmermann, M. O., Klett, T., & Boeckler, F. M. (2023) · Drug Design Development and Therapy · doi:10.2147/dddt.s406703 · Cited by 6

Chemical Strategies towards the Development of Effective Anticancer Peptides

Li, C., & Jin, K. (2023) · Current Medicinal Chemistry · doi:10.2174/0929867330666230426111157 · Cited by 6

Effect of the Flexible Regions of the Oncoprotein Mouse Double Minute X on Inhibitor Binding Affinity

Qin, L., Liu, H., Chen, R., Zhou, J., Cheng, X., Chen, Y., Huang, Y., & Su, Z. (2017) · Biochemistry · doi:10.1021/acs.biochem.7b00903 · Cited by 7

Molecular and Biochemical Techniques for Deciphering p53-MDM2 Regulatory Mechanisms

Karakostis, K., López, I., Peña-Balderas, A. M., Fåhareus, R., & Olivares‐Illana, V. (2020) · Biomolecules · doi:10.3390/biom11010036 · Cited by 7

Editorial of Special Column “Novel Peptides and Peptidomimetics in Drug Discovery”

Cai, J., & Wei, L. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.08.023 · Cited by 6

De Novo Sequencing of Synthetic Bis -cysteine Peptide Macrocycles Enabled by “Chemical Linearization” of Compound Mixtures

Chen, Z., Lim, Y. W., Neo, J. Y., Chan, R. S. T., Koh, L. Q., Yuen, T. Y., Lim, Y. H., Johannes, C. W., & Gates, Z. P. (2023) · Analytical Chemistry · doi:10.1021/acs.analchem.3c01742 · Cited by 6

Elucidation of the solution structure of macrocyclic paritaprevir and exploration of its antitumor potential through molecular docking

Zhang, X., Li, T., Xu, H., Wang, Q., Wu, X., Yan, R., Jin, Y., & Wang, Z. (2024) · Journal of Molecular Liquids · doi:10.1016/j.molliq.2024.125682 · Cited by 5

The Discovery of Potential MDM2 Inhibitors: A Combination of Pharmacophore Modeling, Virtual Screening, Molecular Docking Studies, and in vitro/in vivo Biological Evaluation

Zhang, X., Zhou, C., Yang, Y., Liu, H., Wang, S., Ding, X., & Hu, W. (2021) · ChemMedChem · doi:10.1002/cmdc.202100517 · Cited by 5

Virtual Screening for DNA Repair Inhibitors

Barakat, K., & Tuszyński, J. A. (2011) · InTech eBooks · doi:10.5772/24436 · Cited by 5

Protein Chemical Synthesis in Drug Discovery

Liu, F., & Mayer, J. P. (2014) · Topics in current chemistry · doi:10.1007/128_2014_598 · Cited by 6

In SituHybridization of Superparamagnetic Iron-Biomolecule Nanoparticles

Moghimi, N., Donkor, A. D., Mohapatra, M., Thomas, J. P., Su, Z., Tang, X. S., & Leung, K. T. (2014) · Journal of the American Chemical Society · doi:10.1021/ja505242c · Cited by 5

Functional Interrogation of the N-Terminal Lid of MDMX in p53 Binding via Native Chemical Ligation

Chen, X., & Lu, W. (2016) · Chemical and Pharmaceutical Bulletin · doi:10.1248/cpb.c15-00975 · Cited by 5

Chemical Space Overlap with Critical Protein–Protein Interface Residues in Commercial and Specialized Small‐Molecule Libraries

Si, Y., Xu, D. D., Bum‐Erdene, K., Ghozayel, M. K., Yang, B., Clemons, P. A., & Meroueh, S. O. (2018) · ChemMedChem · doi:10.1002/cmdc.201800537 · Cited by 5

A dimethylbromobenzene-cysteine stapled peptide dual inhibitor of the p53-MDM2/MDMX interactions

Jiang, W., Jin, L., Liu, M., Hou, P., & He, W. (2019) · Hepatoma Research · doi:10.20517/2394-5079.2018.97 · Cited by 5

Discovery of SCY45, a Natural Small‐Molecule MDM2‐p53 Interaction Inhibitor

Gong, H., An, J., Dong, Q., Li, J., Yang, W., Sun, W., Su, Z., & Zhang, S. (2019) · Chemistry & Biodiversity · doi:10.1002/cbdv.201900081 · Cited by 5

Systematic Mutational Analysis of Peptide Inhibition of the p53–MDM2/MDMX Interactions

Li, C. V., Pazgier, M., Li, C., Yuan, W., Liu, M., Wei, G., Lu, W., & Lu, W. (2010) · Journal of Molecular Biology · doi:10.1016/j.jmb.2010.03.005 · Cited by 149

Structural Basis for Inhibition of the MDM2:p53 Interaction by an Optimized MDM2-Binding Peptide Selected with mRNA Display

Nagata, T., Shirakawa, K., Kobayashi, N., Shiheido, H., Tabata, N., Sakuma-Yonemura, Y., Horisawa, K., Katahira, M., Doi, N., & Yanagawa, H. (2014) · PLoS ONE · doi:10.1371/journal.pone.0109163 · Cited by 20

Structure-based Design of High Affinity Peptides Inhibiting the Interaction of p53 with MDM2 and MDMX

Phan, J., Li, Z., Kasprzak, A., Li, B., Sebti, S., Guida, W., Schönbrunn, E., & Chen, J. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.073056 · Cited by 173

Design of ultrahigh-affinity and dual-specificity peptide antagonists of MDM2 and MDMX for P53 activation and tumor suppression

Li, X., Gohain, N., Chen, S., Li, Y., Zhao, X., Li, B., Tolbert, W. D., He, W., Pazgier, M., Hu, H., et al. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.06.010 · Cited by 46

High affinity interaction of the p53 peptide-analogue with human Mdm2 and Mdmx

Czarna, A., Popowicz, G. M., Pęcak, A., Wolf, S., Dubin, G., & Holak, T. A. (2009) · Cell Cycle · doi:10.4161/cc.8.8.8185 · Cited by 99